On the upside
PMC-Sierra (Nasdaq: PMCS) reported lower fourth quarter earnings but the results were better than expected.
Otelco (Nasdaq: OTT) amended and extended the terms of its senior financing.
On the downside
Profit taking sank shares of Keryx Biopharmaceuticals (Nasdaq: KERX). Brightcove (Nasdaq: BCOV) narrowed fourth quarter losses more than expected but the company forecast current quarter results below analyst expectations prompting a downgrade.
Emulex (NYSE: ELX) disappointed with sharply lower second quarter earnings as revenue fell and the data storage equipment maker forecast current quarter results that missed analyst expectations.
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 1 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 index climbed 15 points to 1513.